| 000 | 01626 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517212206.0 | ||
| 264 | 0 | _c20190628 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1536-4844 | ||
| 024 | 7 |
_a10.1093/ibd/izy031 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWaljee, Akbar K | |
| 245 | 0 | 0 |
_aPredicting Corticosteroid-Free Biologic Remission with Vedolizumab in Crohn's Disease. _h[electronic resource] |
| 260 |
_bInflammatory bowel diseases _c05 2018 |
||
| 300 |
_a1185-1192 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdrenal Cortex Hormones |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMachine Learning |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLiu, Boang | |
| 700 | 1 | _aSauder, Kay | |
| 700 | 1 | _aZhu, Ji | |
| 700 | 1 | _aGovani, Shail M | |
| 700 | 1 | _aStidham, Ryan W | |
| 700 | 1 | _aHiggins, Peter D R | |
| 773 | 0 |
_tInflammatory bowel diseases _gvol. 24 _gno. 6 _gp. 1185-1192 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ibd/izy031 _zAvailable from publisher's website |
| 999 |
_c28300631 _d28300631 |
||